Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coron...

Por Gu Youlan L, Fokkema Marieke L, Kampinga Marthe A, de Smet Bart JGL, Tan Eng S, van den Heuvel Ad FM, Zijlstra Felix
Publicado em 2009-09-01

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coron...

Por Gu, Youlan L, Fokkema, Marieke L, Kampinga, Marthe A, de Smet, Bart JGL, Tan, Eng S, van den Heuvel, Ad FM, Zijlstra, Felix
Publicado em 2009

Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impact

Por Mahmoud, Karim D, Gu, Youlan L, Nijsten, Maarten W, de Vos, Ronald, Nieuwland, Wybe, Zijlstra, Felix, Hillege, Hans L, van der Horst, Iwan C, de Smet, Bart JGL
Publicado em 2013

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction

Por Gu, Youlan L., Voors, Adriaan A., Zijlstra, Felix, Hillege, Hans L., Struck, Joachim, Masson, Serge, Vago, Tarcisio, Anker, Stefan D., van den Heuvel, Ad F. M., van Veldhuisen, Dirk J., de Smet, Bart J. G. L.
Publicado em 2011